Lupin Ltd. (LUPIN) 52 Week Low Streak: Second Straight Session Near One-Year Low

Lupin Ltd. 52 Week Low Streak has now run for a second straight session, with the stock trading within 2% of its 52-week low again. Across the streak, the share price has moved down 1.23%, while the latest low touched Rs 1,925.85 and the stock last traded at Rs 1,935.85. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

At the time of writing, Lupin was trading below the previous close of Rs 1,946 after opening at Rs 1,930.95 and moving between Rs 1,925.85 and Rs 1,954.8 during the day. The company’s market capitalisation stood at Rs 89,628.83 crore. For readers tracking Lupin Ltd. 52 Week Low Streak, the key takeaway is not a single-day move, but the fact that the stock has stayed near its yearly low across back-to-back sessions.

Lupin Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 1,935.85
Previous Close	Rs 1,946
Today's Move	Rs -10.15 (-0.52%)
Open	Rs 1,930.95
High	Rs 1,954.8
Low	Rs 1,925.85
Market Capitalisation	Rs 89,628.83 crore

Lupin Ltd. (LUPIN) traded at Rs 1,935.85 versus the previous close of Rs 1,946, a fall of 0.52%. The stock opened at Rs 1,930.95, reached a high of Rs 1,954.8, touched a low of Rs 1,925.85.

Lupin’s share price action today remained weak, with the stock last traded at Rs 1,935.85, down Rs 10.15 or 0.52% from the previous close of Rs 1,946. The day opened at Rs 1,930.95, briefly moved higher to Rs 1,954.8, and then slipped to a low of Rs 1,925.85. That range shows that the stock stayed close to the lower end of the day through much of the move.

The current market capitalisation of Rs 89,628.83 crore places Lupin among the large healthcare names by size, even as the price pattern remains under pressure. The repeated appearance near the 52-week low matters because it signals that the stock is not just weak on one isolated day. Instead, it has stayed near the yearly trough for another session, which makes the Lupin Ltd. 52 Week Low Streak more important than the day’s percentage change alone. For a reader, this kind of pattern is more informative than a one-off intraday dip because it shows persistence of downside across sessions.

What The Repeated 52-Week Lows Show

The Lupin Ltd. 52 Week Low Streak shows that the stock is repeatedly trading near its one-year low rather than reacting to a single sharp move. This is a streak story, not just a daily price story. When a stock stays within 2% of its yearly trough for consecutive sessions, it suggests that the lower price zone is still being tested and that the market has not yet moved away from that area.

Across the streak, Lupin is down 1.23%. That cumulative move is the most useful number for understanding the pattern, because it captures the decline across the full run rather than only the latest trading print. The latest data also shows that the current low of Rs 1,925.85 is the reference point for the repeated yearly-low behaviour. Since no company-specific trigger is confirmed in the available information, the safest reading is that the price pattern is real, while the cause remains unconfirmed.

For investors following the Lupin Ltd. 52 Week Low Streak, the practical question is whether the stock remains trapped near the yearly low or begins to move away from it in the coming sessions. Until that happens, the repeated-low setup remains the main market signal to watch.

Lupin Ltd. (LUPIN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 89,628.83 crore
P/E Ratio	16.1x
P/B Ratio	3.74x
ROE	27.11%
ROCE	28.86%
EPS	Rs 120.9
Book Value Per Share	Rs 520.48
Dividend Yield	0.93%

Lupin Ltd. (LUPIN) fundamental metrics show P/E 16.1x, P/B 3.74x, ROE 27.11%, ROCE 28.86%. These figures provide context only and are not a buy or sell signal.

Lupin Ltd. has a market capitalisation of Rs 89,628.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.1x, P/B at 3.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.11% and ROCE of 28.86%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 120.9, book value per share of Rs 520.48, dividend yield of 0.93%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.7x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	16.1x
Benchmark Median P/E	27.7x
Benchmark Average P/E	40.15x
Benchmark P/E Range	0x to 676.52x
Company P/B Ratio	3.74x
Benchmark Median P/B	2.8x
Company ROE	27.11%
Benchmark Median ROE	11.48%
Company ROCE	28.86%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 89,628.83 crore
Benchmark Median Market Cap	Rs 811.58 crore

Lupin Ltd. (LUPIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Lupin Ltd. (LUPIN) has a P/E ratio of 16.1x, which is below the benchmark median of 27.7x, a difference of -41.88%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Lupin Ltd. (LUPIN) has a ROE of 27.11%, which is above the benchmark median of 11.48%, a difference of +136.15%. Lupin Ltd. (LUPIN) has a ROCE of 28.86%, which is above the benchmark median of 13.28%, a difference of +117.32%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aurobindo Pharma Ltd.	AUROPHARMA	97,014.47	26.39	2.52	9.93	12.76
Mankind Pharma Ltd.	MANKIND	97,850.38	48.51	5.89	12.69	13.24
Dr. Reddy's Laboratories Ltd.	DRREDDY	99,752.64	31.87	2.69	11.69	13.75
Cipla Ltd.	CIPLA	1,05,289.78	31.49	3.02	11.83	16
Laurus Labs Ltd.	LAURUSLABS	1,09,796.85	102.34	19.84	18.31	18.2

Lupin Ltd. (LUPIN) has a P/E ratio of 16.1x compared with the displayed peer median of 31.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.11% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 28.86% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Lupin Ltd. (LUPIN) has a market capitalisation of Rs 89,628.83 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching

• The Lupin Ltd. 52 Week Low Streak has now lasted for a second straight session, keeping the stock near its one-year trough.
• The cumulative move across the streak is -1.23%, which is more useful than today’s change alone.
• The latest low of Rs 1,925.85 is the key reference point for the repeated-low pattern.
• The stock trades at 16.1 times earnings, below the same-industry median, while profitability ratios remain strong.
• Investors tracking Lupin Share Price Today may watch whether the price remains near the yearly low or moves away from it in the next sessions.

About The Company

Lupin Ltd. (LUPIN) is part of India’s healthcare universe and operates in the Pharmaceuticals & Drugs industry. The company is listed on the NSE and BSE, and it is among the larger names in the sector by market capitalisation. In market terms, Lupin is followed closely because its performance often reflects both company-specific developments and broader pharma sentiment.

The stock’s position in the Lupin Ltd. 52 Week Low Streak is important because it combines price weakness with a substantial market size and meaningful profitability ratios. For readers looking at Lupin Stock News or Lupin Share Price Update, the main point is that the price pattern is clear, but the numbers supplied here do not establish a single reason for the repeated proximity to the yearly low.

Frequently Asked Questions

What does Lupin Ltd. 52 Week Low Streak mean?

Ans. It means Lupin has traded within 2% of its 52-week low for consecutive sessions. In this case, the streak has reached a second straight session, showing repeated weakness near the one-year trough.

How much has Lupin moved across the streak?

Ans. Across the current streak, Lupin has moved down 1.23%. That cumulative figure is the best measure of the repeated-low pattern because it captures the full run, not only the latest trading day.

Did Lupin set a new 52-week low today?

Ans. The available data shows Lupin trading near its 52-week low, with the latest low at Rs 1,925.85. It should be read as trading close to that level, not as a claim that a fresh one-year low was confirmed.

Is a company-specific reason confirmed for the repeated weakness?

Ans. No. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline. The price behaviour is visible; the reason is not confirmed in the latest Univest figures.

How does Lupin compare on valuation with peers?

Ans. Lupin’s P/E of 16.1 is below the same-industry median and below several selected peers. Its P/B of 3.74 is above the industry median, so the stock is cheaper on earnings than many peers but not inexpensive on every metric.

What do Lupin’s return ratios show?

Ans. Lupin reports ROE of 27.11% and ROCE of 28.86%, both well above the same-industry medians. Those figures show strong profitability ratios even as the share price remains near its yearly low.

Why is the market capitalisation important here?

Ans. Market capitalisation shows the company’s size, not its quality. Lupin’s market cap of Rs 89,628.83 crore shows it is a large listed pharma company, but the repeated low pattern can still occur in a large-cap name.

What should investors watch next in Lupin Ltd. 52 Week Low Streak?

Ans. Investors should watch whether Lupin stays near the Rs 1,925.85 area or begins trading away from the one-year low zone. The key issue is whether the repeated-low pattern persists into the next sessions or starts to ease.

Track Lupin Ltd. (LUPIN) Share Price on Univest

Use Lupin Ltd. (LUPIN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.